Hematologic Neoplasms: all 1,494 studies
Page 12 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Prophylactic Early PN in HPT/BMTStatus unknownNCT03083327Not applicable
- A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic MalignanciesCompletedNCT03082209Phase 1
- CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.CompletedNCT03067155Phase 2
- Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer SurvivorsCompletedNCT03052777Not applicable
- Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer ParticipantsActive, not recruitingNCT03035604
- A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityCompletedNCT03032783Phase 2
- Multidisciplinary Follow-up of Patients Treated for Malignant Hematological DiseaseStatus unknownNCT03031106
- Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantActive, not recruitingNCT03023631Phase 4
- Patient Fitness and Body Composition During Hematopoietic Stem Cell TransplantationActive, not recruitingNCT02990130
- Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCTSuspendedNCT02988258Phase 1
- Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic MalignanciesTerminatedNCT02985554Phase 1
- The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell TransplantationTerminatedNCT02976558Not applicable
- A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM)CompletedNCT02966457Phase 4
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesSuspendedNCT02962661Phase 1
- PET/CT Guided Antifungal Stewardship in Invasive Pulmonary AspergillosisCompletedNCT02955966Not applicable
- The Oronasal Microbiota in Pediatric Oncology PatientsCompletedNCT02949427
- Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised PatientsStatus unknownNCT02944045Phase 3
- A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological MalignanciesTerminatedNCT02937675Phase 1/2
- Study of IV CBL0137 in Previously Treated Hematological SubjectsTerminatedNCT02931110Phase 1
- Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesCompletedNCT02924402Phase 1
- Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell TransplantationStatus unknownNCT02921685Phase 1
- Early Antibiotic Discontinuation in FUOCompletedNCT02906254
- Effects of Exercise on Allogeneic Stem Cell TransplantStatus unknownNCT02900768Not applicable
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological MalignancyTerminatedNCT02895529Phase 4
- Role of CX3CR1-expressing Cells in Hematologic MalignancyStatus unknownNCT02885623
- The Effect of Special Diets in Hematological Cancer PatientsCompletedNCT02880709Phase 4
- Atezolizumab in Treating Patients With Cancer Following Adoptive Cell TransferActive, not recruitingNCT02862275Phase 1
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
- Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological MalignancyStatus unknownNCT02860598
- Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)CompletedNCT02859623
- T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.TerminatedNCT02849886Phase 1/2
- Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies BTerminatedNCT02844491
- Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data GenerationCompletedNCT02844400
- A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic NeoplasmsCompletedNCT02842229
- Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.CompletedNCT02841124Not applicable
- Clinical Cohort of Lymphoma Patients in MalawiActive, not recruitingNCT02835911
- Impact of Child Positioning on Pain During a Lumbar PunctureCompletedNCT02834156Not applicable
- Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell TransplantationStatus unknownNCT02828878Phase 1/2
- Impact of a Monitoring Device for Patients With Cancer Treated Using Oral TherapeuticsStatus unknownNCT02828462
- Association Between Side Effects Occurrence and Concentrations of Ibrutinib and IdelalisibCompletedNCT02824159
- Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic MalignanciesStatus unknownNCT02813837Not applicable
- Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantCompletedNCT02805075Phase 1
- CD22 Targeting CAR-T Therapy Against B Cell Hematological MalignanciesStatus unknownNCT02794961Phase 1/2
- Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic ToolStatus unknownNCT02791217
- Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data GenerationCompletedNCT02786628
- Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCTWithdrawnNCT02786485Phase 1
- Matching Patients With Hematologic Malignancy to Adequate Clinical TrialsStatus unknownNCT02758080Not applicable
- Phase I Trial of BAY1251152 for Advanced Blood CancersCompletedNCT02745743Phase 1
- PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic MalignanciesCompletedNCT02730312Phase 1
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
- Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT02718755Phase 2
- Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic ImmunotherapyCompletedNCT02710253Phase 2
- Consolidation Therapy in Patients With Hematologic MalignanciesWithdrawnNCT02709993Phase 1/2
- Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) TransplantationCompletedNCT02696408Phase 3
- Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 GenotypesCompletedNCT02680795Phase 1
- To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.TerminatedNCT02679131Phase 1
- CAMELLIA: Anti-CD47 Antibody Therapy in Haematological MalignanciesCompletedNCT02678338Phase 1
- Intravenous Pentamidine for Pneumocystis Jirovecii PneumoniaCompletedNCT02669706
- Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell TransplantCompletedNCT02668315Phase 1/2
- Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot StudyCompletedNCT02650791Phase 3
- Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility DeterminationCompletedNCT02636855
- Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCTCompletedNCT02634294Phase 2/3
- Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly PatientsCompletedNCT02623309Phase 3
- Effect of Smartphone App on ActivityStatus unknownNCT02612402Not applicable
- Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell TransplantCompletedNCT02611063Phase 1
- Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS DeviceActive, not recruitingNCT02600208Phase 2
- Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell TransplantationCompletedNCT02598752
- Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological MalignancyCompletedNCT02583035Not applicable
- Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic MalignanciesCompletedNCT02576496Phase 1
- Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic MalignanciesCompletedNCT02566395Phase 3
- Prognosis of Hematological Cancer Patient Underwent Mechanical VentillationCompletedNCT02562105
- Granulocyte Transfusions in Hematological Patients With Febrile NeutropeniaCompletedNCT02544230
- Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic MalignanciesCompletedNCT02543879Phase 1
- Hu8F4 in Treating Patients With Advanced Hematologic MalignanciesActive, not recruitingNCT02530034Phase 1
- MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCTCompletedNCT02528682Phase 1/2
- Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)Active, not recruitingNCT02515383
- Non Invasive Optical Imaging of WBC CountCompletedNCT02512666Not applicable
- Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood UnitsCompletedNCT02504047Not applicable
- A Study of HMPL-523 in Relapsed or Refractory Hematologic MalignanciesStatus unknownNCT02503033Phase 1
- A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer PatientsCompletedNCT02492789Phase 1
- Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 MutationCompletedNCT02492737Phase 1
- Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic MalignanciesWithdrawnNCT02487459Phase 1
- Allo-HSCT With Alternative Donor in Treatment of Hematologic MalignancyCompletedNCT02487069Not applicable
- Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic TransplantActive, not recruitingNCT02477878Phase 1
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Molecular Disease Profile of Hematological MalignanciesStatus unknownNCT02459743
- Fungemia in Hematologic MalignanciesCompletedNCT02451592
- A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic MalignanciesStatus unknownNCT02386332
- Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult PatientsStatus unknownNCT02385955Phase 2
- A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface AreaCompletedNCT02372357Phase 4
- A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic CancersCompletedNCT02367196Phase 1
- Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating MutationsWithdrawnNCT02355431Phase 2
- A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesCompletedNCT02352558Phase 1
- Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem MalignanciesWithdrawnNCT02343679Phase 2
- Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell TransplantationCompletedNCT02342613Phase 1
- Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic MalignanciesStatus unknownNCT02338479
- Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantSuspendedNCT02333162Phase 1
- Treosulfan-based Conditioning in Paediatric Patients With Haematological MalignanciesCompletedNCT02333058Phase 2
- Pretransplant Evaluation by Supportive Care Team for Patients Undergoing HCT for Hematological MalignanciesCompletedNCT02321345Not applicable